Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded promising discoveries into new therapeutic approaches. Current focus centers on targeting the underlying pathophysiology of MSA. One strategy under investigation involves drug-based interventions to modulate the activi